Publishing research using ab40465? Please let us know so that we can cite the reference in this datasheet.
ab40465 has been referenced in 2 publications.
Takada K et al.Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.J Transl Med 16:86 (2018).
Huard B et al.Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.Proc Natl Acad Sci U S A 94:5744-9 (1997).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up